TWD 31.95
(-10.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 64.72 Million TWD | -27.24% |
2022 | 88.96 Million TWD | 0.05% |
2021 | 88.92 Million TWD | -4.73% |
2020 | 93.34 Million TWD | -10.67% |
2019 | 104.48 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 15.76 Million TWD | -14.04% |
2024 Q2 | 17.68 Million TWD | 12.16% |
2023 Q2 | 12.66 Million TWD | -35.82% |
2023 Q4 | 18.34 Million TWD | 31.03% |
2023 Q1 | 19.72 Million TWD | -28.47% |
2023 FY | 64.72 Million TWD | -27.24% |
2023 Q3 | 13.99 Million TWD | 10.57% |
2022 Q3 | 21.06 Million TWD | 0.0% |
2022 FY | 88.96 Million TWD | 0.05% |
2022 Q4 | 27.57 Million TWD | 30.94% |
2021 FY | 88.92 Million TWD | -4.73% |
2020 FY | 93.34 Million TWD | -10.67% |
2019 FY | 104.48 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -8791.346% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 94.193% |
Level Biotechnology Inc. | 660.61 Million TWD | 90.202% |
Sagittarius Life Science Corp | 440.46 Million TWD | 85.304% |
TaiMed Biologics Inc. | 491.77 Million TWD | 86.838% |
GlycoNex Incorporation | 2.54 Million TWD | -2446.381% |
VBI | 55.85 Million TWD | -15.892% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 71.29% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 79.515% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -220.504% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 83.66% |
Visgeneer Inc. | 147.99 Million TWD | 56.262% |
Mycenax Biotech Inc. | 652.62 Million TWD | 90.082% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 96.168% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 64.325% |
Neith Corporation | 39.9 Million TWD | -62.216% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 83.387% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -184.623% |
Enimmune corporation | 43.49 Million TWD | -48.823% |
TaiRx, Inc. | 5.08 Million TWD | -1173.691% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 93.67% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 75.548% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 84.906% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 41.106% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 64.155% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -5258.361% |
Lukas Biomedical Inc. | 231.83 Million TWD | 72.079% |
RBC Bioscience Corporation | 172.46 Million TWD | 62.469% |
BiOptic Inc. | 228.26 Million TWD | 71.644% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -71821.111% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -579.641% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -1234.619% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 96.477% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -187.928% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 54.15% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -7940.87% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 91.914% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -13.727% |
AP Biosciences Inc | 32.25 Million TWD | -100.691% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 94.409% |
3D Global Biotech Inc. | 20.63 Million TWD | -213.716% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 79.418% |
Intech Biopharm Corporation | 25.84 Million TWD | -150.431% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 25.413% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 91.465% |
TCI GENE Inc. | 333.85 Million TWD | 80.612% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -359505.556% |
Senhwa Biosciences, Inc. | 1 Million TWD | -6372.9% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 24.267% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 59.58% |
PharmaEngine, Inc. | 767.66 Million TWD | 91.568% |
Savior Lifetec Corporation | 1.05 Billion TWD | 93.837% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 47.432% |
OBI Pharma, Inc. | 41.54 Million TWD | -55.79% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 72.378% |
Acepodia, Inc. | 16.59 Million TWD | -290.098% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -66.262% |